David Alberts
Direttore Tecnico/Scientifico/R&S presso Omnitura Therapeutics, Inc.
Posizioni attive di David Alberts
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Omnitura Therapeutics, Inc.
 Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| University of Arizona | Direttore/Membro del Consiglio | 18/09/2009 | - |
Storia della carriera di David Alberts
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
- Borsa valori
- Insiders
- David Alberts
- Esperienza
